Devices
Panel to Review Endovascular Graft Device Endoleaks
CDRH says it will hold a two-day meeting of its Medical Devices Advisory Committee’s Circulatory System Devices Panel to review information about the benefit-risk profile of Endologix’s AFX endovascular graft system pertaining to Type III endoleak risks. The agency intends to request panel feedback on the